Follow on Google News News By Tag * Healthcare * Pharmaceutical * Medical * Medicine * Equipment * Samsung * Nmes * Ratings * Currency * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | New Market Research Report: South Korea Pharmaceuticals & Healthcare Report Q3 2011Fast Market Research recommends "South Korea Pharmaceuticals & Healthcare Report Q3 2011" from Business Monitor International, now available
Headline Expenditure Projections * Pharmaceuticals: * Healthcare: KRW79,058bn (US$68.37bn) * Medical devices: KRW4,151bn (US$3.59bn) in 2010 to KRW4,529bn (US$4.18bn) in 2011; +9.1% in local currency terms and 14.7% in US dollar terms. Our forecast has been revised up moderately from Q211 due to macroeconomic factors. ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Business Environment Rating: South Korea's Pharmaceutical Business Environment Rating (BER) has dropped from 67.9 out of 100 in Q211 to 66.4 in Q311. The downgrade is due to a negative revision to its Industry Rewards, which comprises pharmaceutical market size, per-capita spending on medicines and sector value growth. South Korea retains second place in the 17-country Asia Pacific ratings system. Key Trends & Developments * South Korean units of leading multinational pharmaceutical companies registered a significant rise in sales during 2010, according to financial statements submitted to the Financial Supervisory Service. Novartis Korea posted sales growth rates of 20.3%, while Pfizer Korea and MSD Korea registered a surge of 26.9% and 16.3% respectively. However, the subsidiaries of medium-sized firms including Abbott Korea, Janssen Korea, Bayer Korea, Wyeth Korea and Otsuka Korea saw single-digit sales growth during the same period. The average sales growth for 23 Korean pharmaceutical companies stood at 6%. BMI Economic View: South Korea's current account surplus widened in March 2011, coming in at US$1.4bn from a revised US$1.1bn in February. Both goods exports and imports hit record highs, with the increase in exports exceeding that of imports, boosting the goods surplus. Meanwhile, the services deficit narrowed, as services exports similarly outperformed services imports. While we expect the underlying trend of current account surpluses to remain intact, we note that the upside is limited. As South Korea's oil-intensive economy is very dependent on oil imports (the world's fifth largest net oil importers), elevated oil prices will continue to prop up import costs. BMI Political View: The ruling Grand National Party (GNP) won only one of the three key races during the April 27 by-elections and the disappointing results could stall President Lee Myung-bak's reform drive and exacerbate factionalism within the party. In contrast, the opposition Democratic Party (DP) won both the Bundang and Gangwon races, two areas which were previously thought to have a conservative bias, and this strong resurgence will likely strengthen the party's position within the opposition camp. Partial Table of Contents: Executive Summary SWOT Analysis - South Korea Pharmaceuticals Industry SWOT - South Korea Political SWOT - South Korea Economic SWOT - South Korea Business Environment SWOT Pharmaceutical Business Environment Ratings - Table: Asia Pacific - Regional Business Environment Ratings, Q311 - Rewards - Risks South Korea - Market Summary Regulatory Regime - Regulatory Developments - Controversial Trade Practices - Direct-To-Consumer Advertising - Intellectual Property Regime - Market Access Barriers - Patent Litigation - Pricing Regime - Price Cuts - Reimbursement Regime - Hospital Purchasing - Foreign Trade Developments Industry Trends and Developments - Epidemiology - Non-Communicable Diseases - Communicable Diseases - Healthcare System - Healthcare Financing - National Health Insurance Corporation - Healthcare System Reforms - Medical Tourism - Research and Development - New Molecular Entities (NMEs) Developed By South Korean Drugmakers - Clinical Trials - Biotechnology Sector - Table: South Korea's Bio-Industry Backbone Industry Forecast Scenario - Overall Market Forecast - Table: Pharmaceutical Sales Indicators 2007-2015 - Key Growth Factors - Industry - Table: Healthcare Expenditure Indicators 2007-2015 - Table: Government Healthcare Expenditure Indicators 2007-2015 - Table: Private Healthcare Expenditure Indicators 2007-2015 - Key Growth Factors - Macroeconomic - Table: South Korea - Economic Activity - Prescription Drug Market Forecast - Table: Prescription Drug Sales Indicators 2007-2015 - Patented Drug Market Forecast - Table: Patented Drug Market Indicators 2007-2015 - Generic Drug Market Forecast - Table: Generic Drug Sales Indicators 2007-2015 - OTC Medicine Market Forecast - Table: OTC Medicine Sales Indicators 2007-2015 - Pharmaceutical Trade Forecast - Table: Pharmaceutical Export & Import Indicators 2007-2015 - Medical Device Market Forecast - Table: Classification Of Medical Devices In South Korea - Recent Developments in the Medical Devices Sector - Table: South Korea Medical Devices Forecast 2007-2015 - Other Healthcare Data Forecasts - Full Table of Contents is available at: -- http://www.fastmr.com/ About Business Monitor International Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number